The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2025 | Lai Goldman Myla | Director | Other(J) | 20K | — | — |
| Jul 8, 2025 | Lai Goldman Myla | Director | Other(J) | 39K | — | $0 |
| Jul 8, 2025 | Lai Goldman Myla | Director | Other(J) | 50K | — | $0 |
| Jul 8, 2025 | Lai Goldman Myla | Director | Other(J) | 56K | — | $0 |
| Jul 8, 2025 | Lai Goldman Myla | Director | Other(J) | 31K | — | $0 |
| Jul 8, 2025 | Raffin Thomas A. | Director | Other(J) | 15.9M | — | — |
| Jul 8, 2025 | Raffin Thomas A. | Director | Other(J) | 1.7M | — | — |
| Jul 8, 2025 | Raffin Thomas A. | Director | Other(J) | 235K | — | — |
| Jul 8, 2025 | Raffin Thomas A. | Director | Other(J) | 31K | — | $0 |
| Jul 8, 2025 | Raffin Thomas A. | Director | Other(J) | 56K | — | $0 |
| Jul 8, 2025 | Raffin Thomas A. | Director | Other(J) | 17K | — | $0 |
| Jul 8, 2025 | Raffin Thomas A. | Director | Other(J) | 50K | — | $0 |
| Jul 8, 2025 | Schnettler Thomas P | Director | Other(J) | 56K | — | $0 |
| Jul 8, 2025 | Schnettler Thomas P | Director | Other(J) | 31K | — | $0 |
| Jul 8, 2025 | Schnettler Thomas P | Director | Other(J) | 50K | — | $0 |
| Jul 8, 2025 | Schnettler Thomas P | Director | Other(J) | 17K | — | $0 |
| Jul 8, 2025 | Shepler Robert G | Director | Other(J) | 56K | — | $0 |
| Jul 8, 2025 | Shepler Robert G | Director | Other(J) | 31K | — | $0 |
| Jul 8, 2025 | Shepler Robert G | Director | Other(J) | 50K | — | $0 |
| Jul 8, 2025 | Shepler Robert G | Director | Other(J) | 17K | — | $0 |
| Jul 8, 2025 | Winkler Matthew | Director | Other(J) | 985K | — | — |
| Jul 8, 2025 | Winkler Matthew | Director | Other(J) | 17K | — | $0 |
| Jul 8, 2025 | Winkler Matthew | Director | Other(J) | 31K | — | $0 |
| Jul 8, 2025 | Winkler Matthew | Director | Other(J) | 56K | — | $0 |
| Jul 8, 2025 | Winkler Matthew | Director | Other(J) | 50K | — | $0 |
| Jul 8, 2025 | Bamford Pascal | Chief Clinical Officer | Other(J) | 196K | — | — |
| Jul 8, 2025 | Bamford Pascal | Chief Clinical Officer | Other(J) | 9K | — | — |
| Jul 8, 2025 | Bamford Pascal | Chief Clinical Officer | Other(J) | 50K | — | $0 |
| Jul 8, 2025 | Bamford Pascal | Chief Clinical Officer | Other(J) | 15K | — | $0 |
| Jul 8, 2025 | Bamford Pascal | Chief Clinical Officer | Other(J) | 25K | — | $0 |
| Jul 8, 2025 | Bamford Pascal | Chief Clinical Officer | Other(J) | 150K | — | $0 |
| Jul 8, 2025 | Ek John Frederick | CFO | Other(J) | 54K | — | — |
| Jul 8, 2025 | Ek John Frederick | CFO | Other(J) | 20K | — | — |
| Jul 8, 2025 | Ek John Frederick | CFO | Other(J) | 194K | — | — |
| Jul 8, 2025 | Ek John Frederick | CFO | Other(J) | 70K | — | $0 |
| Jul 8, 2025 | Ek John Frederick | CFO | Other(J) | 160K | — | $0 |
| Jul 8, 2025 | Kamocsay Jennifer | Chief Legal Officer | Other(J) | 163K | — | — |
| Jul 8, 2025 | Kamocsay Jennifer | Chief Legal Officer | Other(J) | 17K | — | — |
| Jul 8, 2025 | Kamocsay Jennifer | Chief Legal Officer | Other(J) | 75K | — | $0 |
| Jul 8, 2025 | Kamocsay Jennifer | Chief Legal Officer | Other(J) | 70K | — | $0 |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 331K | — | — |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 393K | — | — |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Tax withholding(F) | 197K | — | — |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 948K | — | — |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 331K | — | $0 |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 393K | — | $0 |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 242K | — | $0 |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 160K | — | $0 |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 160K | — | $0 |
| Jul 8, 2025 | McKelligon Brian | President and CEO, Director | Other(J) | 175K | — | $0 |
| Jul 8, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Other(J) | 152K | — | — |
| Jul 8, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Other(J) | 131K | — | — |
| Jul 8, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Tax withholding(F) | 42K | — | — |
| Jul 8, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Other(J) | 63K | — | — |
| Jul 8, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Other(J) | 70K | — | $0 |
| Jul 8, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Other(J) | 45K | — | $0 |
| Jul 8, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Other(J) | 45K | — | $0 |
| Jul 8, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Other(J) | 63K | — | $0 |
| Jul 8, 2025 | Mendel Scott | Director | Other(J) | 29K | — | — |
| Jul 8, 2025 | Mendel Scott | Director | Other(J) | 50K | — | $0 |
| Jul 8, 2025 | Mendel Scott | Director | Other(J) | 45K | — | $0 |
| Jul 8, 2025 | Mendel Scott | Director | Other(J) | 56K | — | $0 |
| Jul 8, 2025 | Mendel Scott | Director | Other(J) | 31K | — | $0 |
| Jul 8, 2025 | Mendel Scott | Director | Other(J) | 36K | — | $0 |
| Jun 1, 2025 | Bamford Pascal | Chief Clinical Officer | Tax withholding(F) | 670 | $1.25 | $838 |
| Apr 1, 2025 | Ek John Frederick | CFO | Tax withholding(F) | 16K | $1.35 | $22K |
| Mar 23, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Tax withholding(F) | 2K | $1.70 | $4K |
| Mar 23, 2025 | McKelligon Brian | President and CEO, Director | Tax withholding(F) | 8K | $1.70 | $13K |
| Mar 1, 2025 | McKelligon Brian | President and CEO, Director | Tax withholding(F) | 8K | $1.63 | $12K |
| Mar 1, 2025 | McKelligon Brian | President and CEO, Director | Tax withholding(F) | 8K | $1.63 | $13K |
| Mar 1, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Tax withholding(F) | 4K | $1.63 | $6K |
| Mar 1, 2025 | Ramachandran Niro Ph.D | Chief Business Officer | Tax withholding(F) | 2K | $1.63 | $4K |
| Mar 1, 2025 | Bamford Pascal | Chief Clinical Officer | Tax withholding(F) | 1K | $1.63 | $2K |
| Mar 1, 2025 | Bamford Pascal | Chief Clinical Officer | Tax withholding(F) | 3K | $1.63 | $4K |
| Mar 1, 2025 | Ek John Frederick | CFO | Tax withholding(F) | 4K | $1.63 | $6K |
| Mar 1, 2025 | Kamocsay Jennifer | Chief Legal Officer | Tax withholding(F) | 4K | $1.63 | $6K |
| Mar 1, 2025 | Kamocsay Jennifer | Chief Legal Officer | Tax withholding(F) | 4K | $1.63 | $6K |
| Nov 19, 2024 | McKelligon Brian | President and CEO, Director | Grant(A) | 219K | — | $0 |
| Nov 19, 2024 | Ramachandran Niro Ph.D | Chief Business Officer | Grant(A) | 88K | — | $0 |
| Nov 19, 2024 | Bamford Pascal | Chief Clinical Officer | Grant(A) | 88K | — | $0 |
| Nov 19, 2024 | Ek John Frederick | CFO | Grant(A) | 88K | — | $0 |
| Nov 19, 2024 | Kamocsay Jennifer | Chief Legal Officer | Grant(A) | 88K | — | $0 |
| Oct 2, 2024 | Mendel Scott | Director | Grant(A) | 45K | — | $0 |
| Aug 29, 2024 | Bamford Pascal | Chief Clinical Officer | Grant(A) | 40K | — | $0 |
| Jun 11, 2024 | McKelligon Brian | President and CEO, Director | Sell(S) | 8K | $2.08 | $16K |
| Jun 11, 2024 | McKelligon Brian | President and CEO, Director | Option exercise(M) | 8K | $0.30 | $2K |
| Jun 11, 2024 | McKelligon Brian | President and CEO, Director | Option exercise(M) | 8K | — | $0 |
| Jun 6, 2024 | McKelligon Brian | President and CEO, Director | Option exercise(M) | 8K | $0.30 | $2K |
| Jun 6, 2024 | McKelligon Brian | President and CEO, Director | Sell(S) | 8K | $2.01 | $15K |
| Jun 6, 2024 | McKelligon Brian | President and CEO, Director | Option exercise(M) | 8K | — | $0 |
| Jun 4, 2024 | Mendel Scott | Director | Grant(A) | 50K | — | $0 |
| Jun 4, 2024 | Lai Goldman Myla | Director | Grant(A) | 50K | — | $0 |
| Jun 4, 2024 | Schnettler Thomas P | Director | Grant(A) | 50K | — | $0 |
| Jun 4, 2024 | Winkler Matthew | Director | Grant(A) | 50K | — | $0 |
| Jun 4, 2024 | Shepler Robert G | Director | Grant(A) | 50K | — | $0 |
| Jun 4, 2024 | Raffin Thomas A. | Director | Grant(A) | 50K | — | $0 |
| Apr 1, 2024 | Ek John Frederick | CFO | Tax withholding(F) | 14K | $4.56 | $65K |
| Mar 23, 2024 | McKelligon Brian | President and CEO, Director | Tax withholding(F) | 7K | $4.79 | $34K |
| Mar 23, 2024 | Ramachandran Niro Ph.D | Chief Business Officer | Tax withholding(F) | 2K | $4.79 | $10K |
| Mar 23, 2024 | Pla Frederic | Chief Operating Officer | Tax withholding(F) | 2K | $4.79 | $10K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).